IL1B and type 2 diabetes mellitus: Long-term low-grade inflammatory response and abnormal activation of the immune system are closely related to the development of T2DM, and elevated concentrations of systemic inflammatory markers (IL-1β and IL-6) are risk factors for complications of T2DM [38].